Propofol (2,6-diisopropylphenol), widely used an intravenous anesthetic, is rapidly metabolized to its glucuronide in the in vivo studies. Kinetic parameters for the glucuronidation of propofol and its analogs, such as 2,5-diisopropylphenol, 2-tert-butyl-6-methylphenol, 2-tert-butyl-5-methylphenol, 2,6-dimethylphenol and 2,5-dimethylphenol, were determined in vitro using human and rat liver microsomes. 2,5-Dimethylphenol and 2-tertbutyl-6-methylphenol exhibited the highest and lowest glucuronidation rates, respectively. Substitutes at the 2,6-positions gave lower glucuronidation rates than those at the 2,5-positions in both the human and rat microsomes. 2,5-Diisopropylphenol was glucuronidated at a lower rate in human than propofol. The affinity of uridine 5-diphosphate (UDP)-glucuronosyltransferase for disubstituted phenols, such as propofol, 2,5-diisopropylphenol, 2,5-dimethylphenol, and 2-tert-butyl-6-methylphenol, gave higher K m values in human liver microsomes than in rat ones, and lower V max values showed similar relationship, expect for V max in propofol. The alkyl group at the 6 position showed a higher K m for glucuronidation by a steric hindrance in the human and rat microsomes. Our results propose that the glucuronidation of propofol and its analogs may not be explained by only a steric hindrance.
Propofol (2,6-diisopropylphenol (2,6-DIP)) is widely used as an intravenous anaesthetic for induction and maintenance of anesthesia.
1) It has a short-lasting action resulted from a rapid decay of its plasma concentration. An intravenous dose of propofol in human was metabolized and eliminated up to 88% into the urine for 5 d.
2) The major metabolite was a glucuronic acid conjugate of propofol, and the minor ones were 1-quinol glucuronide, 4-quinol glucuronide and 4-quinol sulphate in human. 3) Propofol glucuronide was also a major metabolite in rat bile. 4) In vitro, propofol was metabolized to its glucuronide 5) and quinol [6] [7] [8] by the microsomes from various tissues of human, rat, hamster, and rabbit. The glucuronidation is catalyzed by uridine 5Ј-diphosphate (UDP)-glucuronosyltransferase (UGT), and the activity has been compared among simple phenolic substrates in human liver microsomes, in which alkyl groups at the ortho position contribute to increasing the K m for UGT and para substitutes give higher V max than the ortho ones. 9) The aim of this study was to compare kinetic properties of propofol and its analogs, meta and/or ortho di-substituted phenolic substrates such as 2,5-diisopropylphenol (2,5-DIP), 2-tert-butyl-6-methylphenol (2,6-TBMP), 2-tert-butyl-5-methylphenol (2,5-TBMP), 2,6-dimethylphenol (2,6-DMP) and 2,5-dimethylphenol (2,5-DMP) (Fig. 1) , using the microsomal fractions from human and rat. Preparation of Rat Liver Microsomes Male Wistar rats (7-8 weeks, Charles River Japan, Inc., Tokyo, Japan) were anesthetized with ether and then sacrificed by exsanguination. Their livers were perfused with ice-cold 1.15% KCl and homogenized in 1 vol. of ice-cold 0.15 M KCl, 2 mM EDTA, and Tris-HCl buffer (pH 7.4). The liver homogenates were centrifuged at 9000ϫg for 25 min and then the supernatant was ultracentrifuged at 105000ϫg for 1 h. The microsomal pellet was suspended in 0.25 M sucrose and recentrifuged at 105000ϫg for 1 h. The resulting microsomal pellet was resuspended in 0.25 M sucrose. Protein concentration was de-termined by the Bradford method using a Bio-rad Protein Assay kit.
MATERIALS AND METHODS

Materials
Measurement of UGT Activity The reactions were performed using the slightly modified method of Le Guellec et al. 10) and Raoof et al. 11) Briefly, the reaction mixture contained 50 mM Tris-HCl (pH 7.4), 10 mM MgCl 2 , each substrate, 0.05% Brij 58, 10 mM d-saccharic acid 1,4-lactone, 3 mM UDPGA and 0.5 mg/ml rat liver microsomes or 1.0 mg/ml pooled human liver microsomes in a final volume of 100 ml. The reaction was preincubated at 37°C for 10 min and then initiated by addition of 3 mM UDPGA. Incubation was carried out at 37°C for 10 min (2,5-DIP, 2,5-DMP, 2,5-TBMP, and 2,6-DMP) or 30 min (2,6-DIP and 2,6-TBMP) and was terminated by addition of an equal volume of icecold methanol. Glucuronide formation was found to be linear for 30 min. After removal of the protein by centrifugation at 3000 rpm for 10 min, aliquots (30 ml) of the reaction mixture were subjected to HPLC. Quantification of glucuronides was carried out with 4-hydroxybiphenyl as the internal standard using a reverse-phase HPLC system (Shimadzu, Kyoto, Japan) equipped with a Capcell Pak C18 UG 120 S-5 (Shiseido Co., Ltd., Tokyo, Japan) (4.6ϫ150 mm). The mobile phase used was acetonitrile : H 2 O : acetic acid (40 : 60 : 0.1) for 2,6-DIP, 2,5-DIP and TBMPs, and acetonitrile : H 2 O : acetic acid (35 : 65 : 0.1) for DMPs at a flow rate of 1 ml/min; detection was carried out at 220 nm with a UV/VIS detector. The retention times for glucuronides of 2,6-DIP, 2,5-DIP, 2,6-TBMP, 2,5-TBMP, 2,6-DMP, and 2,5-DMP and 4-hydroxybiphenyl were 4.5, 6.1, 3.5, 4.7, 2.7, 2.9, and 11 (40% acetonitrile) and 17.7 (35% acetonitrile) min, respectively.
Kinetic Analyses Kinetic parameters were determined from the reaction using rat liver microsomes, with substrate concentrations ranging from 0.0156-1 mM for 2,6-DIP, 0.0156-0.25 mM for 2,5-DIP and 2,5-TBMP, 0.0625-1 mM for 2,6-TBMP and 2,5-DMP, and 0.0625-2 mM for 2,6-DMP. In human liver microsomes, concentrations of the substrates ranged from 0.0625-1 mM for 2,6-DIP and 2,5-DMP, 0.0156-0.25 mM for 2,5-DIP, 0.0325-0.5 mM for 2,5-TBMP, 0.125-2 mM for 2,6-TBMP, and 0.0625-2 mM for 2,6-DMP. The kinetic parameters for each substrate were estimated by fitting the Michaelis-Menten equation to the data using the nonlinear least-squares regression analysis program ADAPT II. 12) 
RESULTS
Glucuronidation of propofol and its analogs was examined using both rat liver microsomes and pooled human liver microsomes from 15 individuals (8 males and 7 females). liver microsomes at various concentrations of substrates. In concentration at 0.25 mM, the highest and lowest glucuronidation rates were obtained for 2,5-DMP (5064.2Ϯ 860.8, 3379.7 pmol/min/mg protein) and 2,6-TBMP (36.8Ϯ 2.2, 3.8 pmol/min/mg protein), respectively. Substitutes at the 2,6-positions gave lower glucuronidation rates than those at the 2,5-positions in the human and rat microsomes. On glucuronidation of 2,6-DIP and 2,5-DIP by the human microsomes, the 2,5-substituted phenols showed lower activities than the 2,6-substituted ones (Fig. 2) . The activities for 2,5-DIP and 2,5-TBMP in human at concentration of 1 mM were 131.5 and 123.4 nmol/min/mg protein, respectively. The activities for 2,5-DIP and 2,5-TBMP were inhibited at high concentrations when compared with substrate concentrations at 0.25 mM and 0.5 mM, respectively. Table 1 shows kinetic parameters for glucuronidation of 2,5-and 2,6-disubstituted phenols in the human microsomes. The highest V max and lowest K m were obtained with 2,5-DMP (8.263 nmol/min/mg protein) and 2,5-DIP (29.3 mM), respectively. The lowest V max and highest K m were obtained with 2,6-TBMP (0.016 nmol/min/mg protein, 770.6 mM), respectively. The K m values for 2,5-substituted compounds were lower than the 2,6-substituted ones. The V max values for 2,5-substituted compounds were higher than those for the 2,6-substituted ones, except that 2,5-DIP showed a lower V max than 2,6-DIP. Table 2 shows kinetic parameters for the glucuronidation in the rat microsomes. The highest V max and the lowest K m were obtained with 2,5-DMP (12.5Ϯ3.21 nmol/min/mg protein) and 2,5-DIP (5.5Ϯ1.3 mM), respectively. The lowest V max and the highest K m were obtained with 2,6-TBMP (0.05Ϯ0.00 nmol/min/mg protein) and 2,6-DMP (683.5Ϯ 62.9 mM), respectively. The K m values of 2,5-substituted phenols were lower than those of the 2,6-substituted ones, whereas the V max values were higher in the 2,5-substituted phenols than the 2,6-substituted ones.
DISCUSSION
Glucuronidation is one of the important metabolic pathways for the clearance of therapeutic drugs, endobiotics and xenobiotics in mammals. This study examined K m and V max for glucuronidation of propofol and its analogs by human and rat liver UGTs, based on the production of metabolites in the presence of UDPGA, and the metabolites were identified on hydrolysis by b-glucuronidase.
High glucuronidation activities were observed in rat liver microsomes compared with human ones for substrates other than propofol (Fig. 2) . The poor activity for propofol by the rat microsomes was consistent with the in vitro results reported by Le Guellec et al. 10) The analogs of propofol were glucuronidated at a higher rate in the rat microsomes than in the human ones. In the human liver microsomes, K m values, indicating the affinity of UGT for propofol (2,6-DIP), 2,5-DIP, and TBMPs, were 5-10 fold of those in rat ones, whereas K m values for DMPs were approximately equivalence. V max values for other substrates than 2,6-DIP by the human liver microsomes were 7-66% of those in the rat ones. These results suggested that the human liver might exhibit a lower glucuronidation capacities because of the high K m and low V max of the human microsomal UGT.
In general, glucuronidation is known to be influenced by three physicochemical parameters, such as log P, pK a , and V m (molecular volume): the ratio log P/V m for the effect of lipophilicity/molecular size might reflects the transport of phenols, such as catechols, to the active site of UGTs, and the pK a is related to the catalytic mechanism.
13) The lipophilicity, being reflected by an increased log P, increased in a possibility for accumulation of the phenols in the hydrophobic environment of UGTs. 14) In our data, log P values, calculated physicochemical parameters of the molecule using the computer program (Pallas Combi, Drug International, INFOCOM CORPORATION, Japan), were well correlated with the measured K m in rat (r 2 ϭ0.79), but poor in human (r 2 ϭ0.18), and the pK a and log P values indicated a higher for 2,6-substituted groups than 2,5-groups.
V max values of these substrates in the human microsomes were in higher order of 2,5-DMPϾ2,6-DMPϾ2,6-DIPϾ2,5-TBMPϾ2,5-DIPϾ2,6-TBMP, and those in the rat were 2,5-DMPϾ2,6-DMPϾ2,5-TBMPϾ2,5-DIPϾ2,6-DIPϾ2,6-TBMP. When V max was compared between 2,5-and 2,6-DIP, there was observed an inversion of V max for 2,5-DIP and 2,6-DIP by human and rat microsomes. As for the inversion, when V max /K m ratios were compared between human and rat microsomes, the ratios were higher for 2,5-DIP than 2,6-DIP coming to the same relation as other substrates. Therefore, these results were explainable from the three parameters, expect for higher V max of propofol in the human microsomes, and from a possibility that alkyl groups at the 6 position led to increase in K m values for glucuronidation in the human and rat, perhaps by a steric hindrance for the phenolic hydroxyl group. 2,5-Substituted substrates, 2,5-DIP and 2,5-TBMP, inhibited glucuronidation at high concentrations in rat and human, indicating a possibility of an in vivo inhibition and drug interaction by these substrates.
However, the inversion remains as a question whether the higher V max may be due to a difference in the activities of UGT-isozymes. It was reported that two human UGT isoforms, UGT1 and UGT2, were involved in propofol glucuronidation.
10) The difference in V max was observed in phenols substituted with bulky sulfonyl groups at various positions: 15) meta-substituted phenol was glucuronidated by human UGT1A1, and ortho-substituted ones was UGT1A9. Catechols were competitively glucuronidated by UGT2B1 and UGT1A6. 13) In conclusion, propofol and its analogs were glucuronidated similarly by the human and rat liver microsomes. A higher V max for propofol by the human microsomes remains unclear. Further study should be conducted to determine the reason why propofol exhibits a higher V max for glucuronidation in the human liver microsomes, using both human recombinant isoenzymes of UGT and inducers for the rat liver UGTs.
